Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 299 entries
Sorted by: Best Match Show Resources per page
Perspectives from the Society for Pediatric Research: advice on sustaining science and mentoring during COVID-19

pipeline programs

Moore DJ, Nguyen ST, Powell WT.
GSID: YkoWY_q3jzAJ
CS Forster, ST Nguyen, WT Powell, DJ Moore, J Ho… - Pediatric …, 2021 - nature.com

The COVID-19 pandemic will leave an indelible mark on the careers of current medical trainees. Given the disruptions to medical education, economic impact on institutions, and …

Physician-Scientist Training and Programming in Pediatric Residency Programs: A National Survey

pipeline programs

Moore DJ, Powell W.
GSID: jH8ABQRajhoJ
AM Burns, DJ Moore, CS Forster, W Powell… - The Journal of …, 2022 - jpeds.com

Methods We surveyed program directors of pediatric residency programs (Appendix 1; available at www. jpeds. com). We aimed to describe the landscape of physician-scientist …

Bridging the divide: Linking basic science to applied psychotherapeutic interventions—A relational frame theory account of cognitive disputation in rational emotive …

Science interventions

Moran DJ.
GSID: QvSD8d45X3sJ
JT Blackledge, DJ Moran, A Ellis - Journal of Rational-Emotive & Cognitive …, 2009 - Springer

… There are plenty of psychotherapy outcome studies documenting the effects of a variety of interventions on a variety of human problems. But the fundamental problem seen so clearly in our rocket science metaphor still remains. Would not clinical...

Cite
Blackledge, J. T., Moran, D. J., & Ellis, A. (2009). Bridging the divide: Linking basic science to applied psychotherapeutic interventions—A relational frame theory account of cognitive disputation in rational emotive behavior therapy. Journal of Rational-Emotive & Cognitive-Behavior Therapy, 27(4), 232-248.
Blackledge, John T., Daniel J. Moran, and Albert Ellis. "Bridging the divide: Linking basic science to applied psychotherapeutic interventions—A relational frame theory account of cognitive disputation in rational emotive behavior therapy." Journal of Rational-Emotive & Cognitive-Behavior Therapy 27.4 (2009): 232-248.
Copy Download .nbib Format: MLA
Robust upward dispersion of the neutron spin resonance in the heavy fermion superconductor Ce.

Nature communications

Song Y, Van Dyke J, Lum IK, White BD, Jang S, Yazici D, Shu L, Schneidewind A, Čermák P, Qiu Y, Maple MB, Morr DK, Dai P.
PMID: 27677397
Nat Commun. 2016 Sep 28;7:12774. doi: 10.1038/ncomms12774.

The neutron spin resonance is a collective magnetic excitation that appears in the unconventional copper oxide, iron pnictide and heavy fermion superconductors. Although the resonance is commonly associated with a spin-exciton due to the d(s

Cite
Song Y, Van Dyke J, Lum IK, et al. Robust upward dispersion of the neutron spin resonance in the heavy fermion superconductor Ce. Nat Commun. 2016;7:12774doi: 10.1038/ncomms12774.
Song, Y., Van Dyke, J., Lum, I. K., White, B. D., Jang, S., Yazici, D., Shu, L., Schneidewind, A., Čermák, P., Qiu, Y., Maple, M. B., Morr, D. K., & Dai, P. (2016). Robust upward dispersion of the neutron spin resonance in the heavy fermion superconductor Ce. Nature communications, 712774. https://doi.org/10.1038/ncomms12774
Song, Yu, et al. "Robust upward dispersion of the neutron spin resonance in the heavy fermion superconductor Ce." Nature communications vol. 7 (2016): 12774. doi: https://doi.org/10.1038/ncomms12774
Song Y, Van Dyke J, Lum IK, White BD, Jang S, Yazici D, Shu L, Schneidewind A, Čermák P, Qiu Y, Maple MB, Morr DK, Dai P. Robust upward dispersion of the neutron spin resonance in the heavy fermion superconductor Ce. Nat Commun. 2016 Sep 28;7:12774. doi: 10.1038/ncomms12774. PMID: 27677397; PMCID: PMC5052703.
Copy Download .nbib Format: NLM
Tuberculous pleural effusions: advances and controversies.

Journal of thoracic disease

Vorster MJ, Allwood BW, Diacon AH, Koegelenberg CF.
PMID: 26150911
J Thorac Dis. 2015 Jun;7(6):981-91. doi: 10.3978/j.issn.2072-1439.2015.02.18.

On a global scale, tuberculosis (TB) remains one of the most frequent causes of pleural effusions. Our understanding of the pathogenesis of the disease has evolved and what was once thought to be an effusion as a result of...

Cite
Vorster MJ, Allwood BW, Diacon AH, et al. Tuberculous pleural effusions: advances and controversies. J Thorac Dis. 2015;7(6):981-91doi: 10.3978/j.issn.2072-1439.2015.02.18.
Vorster, M. J., Allwood, B. W., Diacon, A. H., & Koegelenberg, C. F. (2015). Tuberculous pleural effusions: advances and controversies. Journal of thoracic disease, 7(6), 981-91. https://doi.org/10.3978/j.issn.2072-1439.2015.02.18
Vorster, Morné J, et al. "Tuberculous pleural effusions: advances and controversies." Journal of thoracic disease vol. 7,6 (2015): 981-91. doi: https://doi.org/10.3978/j.issn.2072-1439.2015.02.18
Vorster MJ, Allwood BW, Diacon AH, Koegelenberg CF. Tuberculous pleural effusions: advances and controversies. J Thorac Dis. 2015 Jun;7(6):981-91. doi: 10.3978/j.issn.2072-1439.2015.02.18. PMID: 26150911; PMCID: PMC4466424.
Copy Download .nbib Format: NLM
Structural Properties of Phospholipid-based Bilayers with Long-Chain Alcohol Molecules in the Gel Phase.

The journal of physical chemistry. B

Hartkamp R, Moore TC, Iacovella CR, Thompson MA, Bulsara PA, Moore DJ, McCabe C.
PMID: 27957835
J Phys Chem B. 2016 Dec 22;120(50):12863-12871. doi: 10.1021/acs.jpcb.6b10192. Epub 2016 Dec 13.

The structural properties of two-component gel-phase bilayers of distearylphosphatidylcholine (DSPC) and alcohol molecules with different compositions and chain lengths (12-24 carbons long) are studied via molecular dynamics simulations. Several bilayer properties, including area per lipid, tilt angle, chain interdigitation,...

Cite
Hartkamp R, Moore TC, Iacovella CR, et al. Structural Properties of Phospholipid-based Bilayers with Long-Chain Alcohol Molecules in the Gel Phase. J Phys Chem B. 2016;120(50):12863-12871doi: 10.1021/acs.jpcb.6b10192.
Hartkamp, R., Moore, T. C., Iacovella, C. R., Thompson, M. A., Bulsara, P. A., Moore, D. J., & McCabe, C. (2016). Structural Properties of Phospholipid-based Bilayers with Long-Chain Alcohol Molecules in the Gel Phase. The journal of physical chemistry. B, 120(50), 12863-12871. https://doi.org/10.1021/acs.jpcb.6b10192
Hartkamp, Remco, et al. "Structural Properties of Phospholipid-based Bilayers with Long-Chain Alcohol Molecules in the Gel Phase." The journal of physical chemistry. B vol. 120,50 (2016): 12863-12871. doi: https://doi.org/10.1021/acs.jpcb.6b10192
Hartkamp R, Moore TC, Iacovella CR, Thompson MA, Bulsara PA, Moore DJ, McCabe C. Structural Properties of Phospholipid-based Bilayers with Long-Chain Alcohol Molecules in the Gel Phase. J Phys Chem B. 2016 Dec 22;120(50):12863-12871. doi: 10.1021/acs.jpcb.6b10192. Epub 2016 Dec 13. PMID: 27957835.
Copy Download .nbib Format: NLM
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).

Chemical communications (Cambridge, England)

Robb CM, Contreras JI, Kour S, Taylor MA, Abid M, Sonawane YA, Zahid M, Murry DJ, Natarajan A, Rana S.
PMID: 28636052
Chem Commun (Camb). 2017 Jul 04;53(54):7577-7580. doi: 10.1039/c7cc03879h.

Cyclin-dependent kinase 9 (CDK9), a member of the cyclin-dependent protein kinase (CDK) family, is involved in transcriptional elongation of several target genes. CDK9 is ubiquitously expressed and has been shown to contribute to a variety of malignancies such as...

Cite
Robb CM, Contreras JI, Kour S, et al. Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chem Commun (Camb). 2017;53(54):7577-7580doi: 10.1039/c7cc03879h.
Robb, C. M., Contreras, J. I., Kour, S., Taylor, M. A., Abid, M., Sonawane, Y. A., Zahid, M., Murry, D. J., Natarajan, A., & Rana, S. (2017). Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical communications (Cambridge, England), 53(54), 7577-7580. https://doi.org/10.1039/c7cc03879h
Robb, Caroline M, et al. "Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)." Chemical communications (Cambridge, England) vol. 53,54 (2017): 7577-7580. doi: https://doi.org/10.1039/c7cc03879h
Robb CM, Contreras JI, Kour S, Taylor MA, Abid M, Sonawane YA, Zahid M, Murry DJ, Natarajan A, Rana S. Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chem Commun (Camb). 2017 Jul 04;53(54):7577-7580. doi: 10.1039/c7cc03879h. PMID: 28636052; PMCID: PMC5555382.
Copy Download .nbib Format: NLM
Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer.

Advanced functional materials

Ngamcherdtrakul W, Morry J, Gu S, Castro DJ, Goodyear SM, Sangvanich T, Reda MM, Lee R, Mihelic SA, Beckman BL, Hu Z, Gray JW, Yantasee W.
PMID: 26097445
Adv Funct Mater. 2015 May 13;25(18):2646-2659. doi: 10.1002/adfm.201404629.

No abstract available.

Cite
Ngamcherdtrakul W, Morry J, Gu S, et al. Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer. Adv Funct Mater. 2015;25(18):2646-2659doi: 10.1002/adfm.201404629.
Ngamcherdtrakul, W., Morry, J., Gu, S., Castro, D. J., Goodyear, S. M., Sangvanich, T., Reda, M. M., Lee, R., Mihelic, S. A., Beckman, B. L., Hu, Z., Gray, J. W., & Yantasee, W. (2015). Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer. Advanced functional materials, 25(18), 2646-2659. https://doi.org/10.1002/adfm.201404629
Ngamcherdtrakul, Worapol, et al. "Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer." Advanced functional materials vol. 25,18 (2015): 2646-2659. doi: https://doi.org/10.1002/adfm.201404629
Ngamcherdtrakul W, Morry J, Gu S, Castro DJ, Goodyear SM, Sangvanich T, Reda MM, Lee R, Mihelic SA, Beckman BL, Hu Z, Gray JW, Yantasee W. Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer. Adv Funct Mater. 2015 May 13;25(18):2646-2659. doi: 10.1002/adfm.201404629. PMID: 26097445; PMCID: PMC4469082.
Copy Download .nbib Format: NLM
Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity.

Neurobehavioral HIV medicine

Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman BB, Morgello S, Moore DJ, Levine AJ.
PMID: 26617462
Neurobehav HIV Med. 2013;5:11-22. doi: 10.2147/NBHIV.S39573. Epub 2013 Jun 19.

BACKGROUND: The apolipoprotein-E (APOE) ε4 allele is a risk factor for vascular dementia and Alzheimer's disease. Recent studies are equivocal with regards to whether or not the ε4 allele confers increased risk for the development of human immunodeficiency virus...

Cite
Panos SE, Hinkin CH, Singer EJ, et al. Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehav HIV Med. 2013;5:11-22doi: 10.2147/NBHIV.S39573.
Panos, S. E., Hinkin, C. H., Singer, E. J., Thames, A. D., Patel, S. M., Sinsheimer, J. S., Del Re, A. C., Gelman, B. B., Morgello, S., Moore, D. J., & Levine, A. J. (2013). Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehavioral HIV medicine, 511-22. https://doi.org/10.2147/NBHIV.S39573
Panos, Stella E, et al. "Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity." Neurobehavioral HIV medicine vol. 5 (2013): 11-22. doi: https://doi.org/10.2147/NBHIV.S39573
Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman BB, Morgello S, Moore DJ, Levine AJ. Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehav HIV Med. 2013;5:11-22. doi: 10.2147/NBHIV.S39573. Epub 2013 Jun 19. PMID: 26617462; PMCID: PMC4659385.
Copy Download .nbib Format: NLM
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.

Clinical proteomics

Morré DJ, Hostetler B, Taggart DJ, Morré DM, Musk AW, Robinson BW, Creaney J.
PMID: 26807072
Clin Proteomics. 2016 Jan 22;13:2. doi: 10.1186/s12014-016-9103-3. eCollection 2016.

BACKGROUND: Malignant mesothelioma is an aggressive, almost uniformly fatal tumor, caused primarily by exposure to asbestos. In this study, serum presence of mesothelioma-specific protein transcript variants of ecto-nicotinamide adenine dinucleotide oxidase disulfide-thiol exchanger 2 (ENOX2), a recently identified marker...

Cite
Morré DJ, Hostetler B, Taggart DJ, et al. ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms. Clin Proteomics. 2016;13:2doi: 10.1186/s12014-016-9103-3.
Morré, D. J., Hostetler, B., Taggart, D. J., Morré, D. M., Musk, A. W., Robinson, B. W., & Creaney, J. (2016). ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms. Clinical proteomics, 132. https://doi.org/10.1186/s12014-016-9103-3
Morré, D James, et al. "ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms." Clinical proteomics vol. 13 (2016): 2. doi: https://doi.org/10.1186/s12014-016-9103-3
Morré DJ, Hostetler B, Taggart DJ, Morré DM, Musk AW, Robinson BW, Creaney J. ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms. Clin Proteomics. 2016 Jan 22;13:2. doi: 10.1186/s12014-016-9103-3. eCollection 2016. PMID: 26807072; PMCID: PMC4724078.
Copy Download .nbib Format: NLM
Patents and literature.

Applied biochemistry and biotechnology

Smith JA, Luenser SJ, Olson NF, Magee EL, Olivieri R, Viglia A, Degen L, Angelini L, Fascetti E, Miwa N, Masuda Y, Kawarabuki S, Sai T, Saito T, Busby MG, Hartwig DW, Heady R, Yagi Y, Kouno K, Inui T, Marshall JJ, Thomson AR, Miles BJ, Caygill JC, Moore DJ, Nakamura K, Nankai S, Iijima T, Ooshima Y, Baldeschwieler JD, Gamble RC, Mauk MR, Shen TY, Ponpipom MM, Khachatourians GG, Zaffaroni P, Senni A, Formiconi L, Blair JE, Davis LT, Cabane B, Vergnault J, Volesky B, Tsezos M, Bull FG, Messing RA, Ahnell JE, Chen LF, Gong CS, Tsao GT, Katsumata R, Green S, Leiser RS, Fedde PA, Ghosh S, Henry MP, Klass DL, Uemura Y, Arimura H, Morise H, Funakoshi S, Suyama T, Lützen NW, Kita DA, Fenton DM, Maclennan DG, Ousby JC, Owen TR, Steer DC, Araujo FJ, Calderon IL, Diaz IL, Olmedo C, Rebeller M, Yout P, Lonchamp D, Mynatt RL, Berg A, Eckmayer Z, Maselli JA, Horwath RO, Gotou E, Satou K, Wu RJ, Bahl CP, Narang SA, Hershberger CL, Baxter JD, Roberts JL, Seeburg PH, Goodman HM, Tsuchida T.
PMID: 24234462
Appl Biochem Biotechnol. 1982 Nov;7(6):497-510. doi: 10.1007/BF02799180.

No abstract available.

Cite
Smith JA, Luenser SJ, Olson NF, et al. Patents and literature. Appl Biochem Biotechnol. 1982;7(6):497-510doi: 10.1007/BF02799180.
Smith, J. A., Luenser, S. J., Olson, N. F., Magee, E. L., Olivieri, R., Viglia, A., Degen, L., Angelini, L., Fascetti, E., Miwa, N., Masuda, Y., Kawarabuki, S., Sai, T., Saito, T., Busby, M. G., Hartwig, D. W., Heady, R., Yagi, Y., Kouno, K., Inui, T., Marshall, J. J., Thomson, A. R., Miles, B. J., Caygill, J. C., Moore, D. J., Nakamura, K., Nankai, S., Iijima, T., Ooshima, Y., Baldeschwieler, J. D., Gamble, R. C., Mauk, M. R., Shen, T. Y., Ponpipom, M. M., Khachatourians, G. G., Zaffaroni, P., Senni, A., Formiconi, L., Blair, J. E., Davis, L. T., Cabane, B., Vergnault, J., Volesky, B., Tsezos, M., Bull, F. G., Messing, R. A., Ahnell, J. E., Chen, L. F., Gong, C. S., Tsao, G. T., Katsumata, R., Green, S., Leiser, R. S., Fedde, P. A., Ghosh, S., Henry, M. P., Klass, D. L., Uemura, Y., Arimura, H., Morise, H., Funakoshi, S., Suyama, T., Lützen, N. W., Kita, D. A., Fenton, D. M., Maclennan, D. G., Ousby, J. C., Owen, T. R., Steer, D. C., Araujo, F. J., Calderon, I. L., Diaz, I. L., Olmedo, C., Rebeller, M., Yout, P., Lonchamp, D., Mynatt, R. L., Berg, A., Eckmayer, Z., Maselli, J. A., Horwath, R. O., Gotou, E., Satou, K., Wu, R. J., Bahl, C. P., Narang, S. A., Hershberger, C. L., Baxter, J. D., Roberts, J. L., Seeburg, P. H., Goodman, H. M., & Tsuchida, T. (1982). Patents and literature. Applied biochemistry and biotechnology, 7(6), 497-510. https://doi.org/10.1007/BF02799180
Smith, J A, et al. "Patents and literature." Applied biochemistry and biotechnology vol. 7,6 (1982): 497-510. doi: https://doi.org/10.1007/BF02799180
Smith JA, Luenser SJ, Olson NF, Magee EL, Olivieri R, Viglia A, Degen L, Angelini L, Fascetti E, Miwa N, Masuda Y, Kawarabuki S, Sai T, Saito T, Busby MG, Hartwig DW, Heady R, Yagi Y, Kouno K, Inui T, Marshall JJ, Thomson AR, Miles BJ, Caygill JC, Moore DJ, Nakamura K, Nankai S, Iijima T, Ooshima Y, Baldeschwieler JD, Gamble RC, Mauk MR, Shen TY, Ponpipom MM, Khachatourians GG, Zaffaroni P, Senni A, Formiconi L, Blair JE, Davis LT, Cabane B, Vergnault J, Volesky B, Tsezos M, Bull FG, Messing RA, Ahnell JE, Chen LF, Gong CS, Tsao GT, Katsumata R, Green S, Leiser RS, Fedde PA, Ghosh S, Henry MP, Klass DL, Uemura Y, Arimura H, Morise H, Funakoshi S, Suyama T, Lützen NW, Kita DA, Fenton DM, Maclennan DG, Ousby JC, Owen TR, Steer DC, Araujo FJ, Calderon IL, Diaz IL, Olmedo C, Rebeller M, Yout P, Lonchamp D, Mynatt RL, Berg A, Eckmayer Z, Maselli JA, Horwath RO, Gotou E, Satou K, Wu RJ, Bahl CP, Narang SA, Hershberger CL, Baxter JD, Roberts JL, Seeburg PH, Goodman HM, Tsuchida T. Patents and literature. Appl Biochem Biotechnol. 1982 Nov;7(6):497-510. doi: 10.1007/BF02799180. PMID: 24234462.
Copy Download .nbib Format: NLM
Training physicians to be competent communicators.

Southern medical journal

Morris DJ.
PMID: 9496882
South Med J. 1998 Feb;91(2):218. doi: 10.1097/00007611-199802000-00022.

No abstract available.

Cite
Morris DJ. Training physicians to be competent communicators. South Med J. 1998;91(2):218doi: 10.1097/00007611-199802000-00022.
Morris, D. J. (1998). Training physicians to be competent communicators. Southern medical journal, 91(2), 218. https://doi.org/10.1097/00007611-199802000-00022
Morris, D J. "Training physicians to be competent communicators." Southern medical journal vol. 91,2 (1998): 218. doi: https://doi.org/10.1097/00007611-199802000-00022
Morris DJ. Training physicians to be competent communicators. South Med J. 1998 Feb;91(2):218. doi: 10.1097/00007611-199802000-00022. PMID: 9496882.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 299 entries